Esophageal cancer is most often caused by either squamous cell carcinoma along the inner lining of the esophagus or by adenocarcinoma, malignant tumors of the gland cells. Adenocarcinoma is occurring more often in patients and is closely linked to acid reflux and reflux related disorders.
Anthony A. Starpoli, MD | www.starpoli.com
HealthDay reports 78% increased risk of cancer in GERD patients, but simple antacids appear to lower the risk, researchers report
Anthony A. Starpoli, MD | www.starpoli.com
As reported by Medscape, according to research presented at the Digestive Disease Week meeting, “patients with gastroesophageal reflux disease (GERD) might benefit more from transoral incisionless fundoplication (TIF) than from continued treatment with proton-pump inhibitors (PPIs).” The study’s lead author Karim Trad, MD, said, “In this study, transoral incisionless fundoplication was superior to maximal-dose PPIs in eliminating daily troublesome typical and atypical symptoms in selected patients.” Dr. Trad added that the findings “establish for the first time that, for some patients, the procedure is better than maximal-dose PPI therapy for controlling a range of GERD symptoms.”
Anthony A. Starpoli, MD | www.starpoli.com
hiatal hernia, fundoplication, LINX, GERD, atypical reflux, EsophyX, incisionless surgery, esophageal cancer
Esophageal cancer rates have risen by 50% over the past 25 years in men in the United Kingdom, according to new figures released by Cancer Research UK.
Anthony A. Starpoli, MD | www.starpoli.com
cancer screening, Reflux, GERD, esophageal cancer, Barrett's Esophagus
